#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Sushma Shivaswamy Email
Chief Scientific Officer . XBiotech USA
How to contact Sushma Shivaswamy
Join and see Sushma's contact info for free!Current Roles
Employees:
117Revenue:
$19.2MAbout
XBiotech is developing a first-in-class monoclonal antibody (MABp1) to inhibit chronic inflammation. Chronic (sterile) inflammatory responses are involved in the progression of many serious and common diseases. MABp1 is being investigated in many important areas of medicine, including: cancer, leukemia (Phase 1); Type 2 diabetes (Phase2); Psoriasis (Phase 2); and vascular disease (Phase 2). MABp1 is a True Human antibody cloned from a natural human immune response andunlike currently marketed antibodiesit has not undergone any modification to alter its function. It has exhibited the best potential tolerability and safety during the clinical trials. XBiotech has established a current good manufacturing practices (cGMP) program to commercialize its lead product candidate. The Company has purchased land and designed a commercial-scale plant with 25,000L total bioreactor capacity. Construction of the facility is planned to commence in 4th quarter 2011..XBiotech USA Address
5217 WINNEBAGO LN.Austin, TX
United States